Skip to main content

Advertisement

SpringerLink
Log in

Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

A breast cancer risk prediction rule previously developed by Rosner and Colditz has reasonable predictive ability. We developed a re-fitted version of this model, based on more than twice as many cases now including women up to age 85, and further extended it to a model that distinguished risk factor prediction of tumors with different estrogen/progesterone receptor status.

Methods

We compared the calibration and discriminatory ability of the original, the re-fitted, and the type-specific models. Evaluation used data from the Nurses’ Health Study during the period 1980–2008, when 4384 incident invasive breast cancers occurred over 1.5 million person-years. Model development used two-thirds of study subjects and validation used one-third.

Results

Predicted risks in the validation sample from the original and re-fitted models were highly correlated (ρ = 0.93), but several parameters, notably those related to use of menopausal hormone therapy and age, had different estimates. The re-fitted model was well-calibrated and had an overall C-statistic of 0.65. The extended, type-specific model identified several risk factors with varying associations with occurrence of tumors of different receptor status. However, this extended model relative to the prediction of any breast cancer did not meaningfully reclassify women who developed breast cancer to higher risk categories, nor women remaining cancer free to lower risk categories.

Conclusions

The re-fitted Rosner-Colditz model has applicability to risk prediction in women up to age 85, and its discrimination is not improved by consideration of varying associations across tumor subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886

    Article  CAS  PubMed  Google Scholar 

  2. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541–1548

    Article  CAS  PubMed  Google Scholar 

  3. Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L (2007) Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 99(23):1782–1792

    Article  PubMed  Google Scholar 

  4. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH (2011) Projecting individualized absolute invasive breast cancer risk in asian and pacific islander american women. JNCI 103:951–961

    Article  PubMed  PubMed Central  Google Scholar 

  5. Division of cancer epidemiology and genetics. Breast cancer risk assessment macro BrCa_RAM.sas. Downloaded from http://dceg.cancer.gov/tools/risk-assessment/bcrasasmacro

  6. Rosner B, Colditz GA (1996) Nurses’ health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 88:359–364

    Article  CAS  PubMed  Google Scholar 

  7. Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses’ health study. Am J Epidemiol 152:950–964

    Article  CAS  PubMed  Google Scholar 

  8. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96:218–228

    Article  CAS  PubMed  Google Scholar 

  9. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA et al (2001) Validation of the Gail model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93(5):358–366

    Article  CAS  PubMed  Google Scholar 

  10. Boyle P, Mezzetti M, La Vecchia C, Franceschi S, Decarli A, Robertson C (2004) Contribution of three components to individual cancer risk predicting breast cancer risk in Italy. Eur J Cancer Prev 13:183–191

    Article  CAS  PubMed  Google Scholar 

  11. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111–1130

    Article  PubMed  Google Scholar 

  12. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227–236

    Article  CAS  PubMed  Google Scholar 

  13. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204–1214

    Article  PubMed  Google Scholar 

  14. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K (2008) Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 148:337–347

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mavaddat N, Pharoah PD, Michailidou K et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. doi:10.1093/jnci/djv036

    PubMed  PubMed Central  Google Scholar 

  16. Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796–2803

    Article  CAS  PubMed  Google Scholar 

  17. Tamimi RM, Rosner B, Colditz GA (2010) Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer 116:4944–4953

    Article  PubMed  PubMed Central  Google Scholar 

  18. Meads C, Ahmed I, Riley RD (2012) A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat 132:365–377

    Article  PubMed  Google Scholar 

  19. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM (2013) Breast cancer follow-up and management after primary treatment: American Society of clinical oncology clinical practice guideline update. J Clin Oncol 31:2942–2962

    Article  PubMed  Google Scholar 

  20. Colditz GA, Hankinson SE (2005) The nurses’ health study: lifestyle and health among women. Nat Rev Cancer 5:388–396

    Article  CAS  PubMed  Google Scholar 

  21. Rosner B, Glynn RJ, Tamimi RM, Chen WY, Colditz GA, Willett WC, Hankinson SE (2013) Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol 178:296–308

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hefti MM, Hu R, Knoblauch NW, Collins LC, Haibe-Kains B, Tamimi RM, Beck AH (2013) Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. Breast Cancer Res 15:R68

    Article  PubMed  PubMed Central  Google Scholar 

  23. Prentice RL, Gloeckler LA (1978) Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34(1):57–67

    Article  CAS  PubMed  Google Scholar 

  24. Wu M, Ware JH (1979) On the use of repeated measurements in regression analysis with dichotomous responses. Biometrics 35(2):513–521

    Article  CAS  PubMed  Google Scholar 

  25. D’Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB (1990) Relation of pooled logistic regression to time dependent Cox regression analysis: the framingham heart study. Stat Med 9(12):1501–1515

    Article  PubMed  Google Scholar 

  26. Glynn RJ, Rosner B (2004) Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol 57:113–122

    Article  PubMed  Google Scholar 

  27. Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS (2014) Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology. 25:114–121

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E (2016) Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat 159:513–525

    Article  PubMed  Google Scholar 

  29. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ (2015) The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. doi:10.1093/jnci/dju397

    Google Scholar 

  30. Tworoger SS, Zhang X, Eliassen AH, Qian J, Colditz GA, Willett WC, Rosner BA, Kraft P, Hankinson SE (2014) Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol 32:3111–3117

    Article  PubMed  PubMed Central  Google Scholar 

  31. Steinkellner AR, Denison SE, Eldridge SL, Lenzi LL, Chen W, Bowlin SJ (2012) A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the women’s health initiative. Menopause 19:616–621

    Article  PubMed  Google Scholar 

  32. Rosner BA, Colditz GA, Hankinson SE, Sullivan-Halley J, Lacey JV Jr, Bernstein L (2013) Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California teachers study. Breast Cancer Res Treat 142:187–202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York

    Book  Google Scholar 

Download references

Funding

This project was funded by a cohort infrastructure Grant (UM1 CA186107), and a program project Grant (P01 CA87969) from the National Cancer Institute.

Author information

Authors and Affiliations

  1. Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Robert J. Glynn, Rulla M. Tamimi, Wendy Y. Chen, Susan E. Hankinson, Walter W. Willett & Bernard Rosner

  2. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Robert J. Glynn & Bernard Rosner

  3. Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Robert J. Glynn

  4. Alvin J. Siteman Cancer Center and Department of Surgery, Division of Public Health Sciences, School of Medicine, Washington University of St. Louis, St. Louis, MO, USA

    Graham A. Colditz

  5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Rulla M. Tamimi & Susan E. Hankinson

  6. Dana-Farber Cancer Institute, Boston, MA, USA

    Wendy Y. Chen

  7. Division of Biostatistics and Epidemiology, School of Public Health Sciences, University of Massachusetts, Amherst, MA, USA

    Susan E. Hankinson

  8. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Walter W. Willett

Authors
  1. Robert J. Glynn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graham A. Colditz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rulla M. Tamimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wendy Y. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susan E. Hankinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Walter W. Willett
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bernard Rosner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Glynn.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glynn, R.J., Colditz, G.A., Tamimi, R.M. et al. Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk. Breast Cancer Res Treat 165, 215–223 (2017). https://doi.org/10.1007/s10549-017-4319-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4319-0

Keywords

Search

Navigation